Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2
Gladstone Institutes · University of California, San Francisco · +2 more institutions
Abstract
Abstract Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, yet its etiology remains poorly understood. We used ‘omic” assays and serology to deeply characterize the global and SARS-CoV-2-specific immunity in the blood of individuals with clear LC and non-LC clinical trajectories, 8 months postinfection. We found that LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution implying ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets. LC individuals displayed increased frequencies of CD4 + T cells poised to migrate to…
Citation impact
- FWCI
- 106.15
- Percentile
- 100%
- References
- 50
Authors
30- KYKailin YinCorresponding
Gladstone Institutes, University of California, San Francisco
- MJMichael J. Peluso
University of California, San Francisco
- XLXiaoyu Luo
Gladstone Institutes, University of California, San Francisco
- RTReuben Thomas
Gladstone Institutes, University of California, San Francisco
- MSMin‐Gyoung Shin
Gladstone Institutes, University of California, San Francisco
Topics & keywords
- Immune system
- Immunology
- Inflammation
- Acquired immune system
- Immune dysregulation
- CD8
- Immunity
- Antibody
- Good health and well-being
Funding
- GMGeorge Mason University
- SFSandler Foundation
- GIGladstone Institutes
- RFRoddenberry Foundation
- JBJames B. Pendleton Charitable Trust
- FGFast Grants
- DFDeutsche ForschungsgemeinschaftAwards: 316249678, SFB 1279, 316249678-SFB 1279
- NINational Institutes of HealthAwards: 3R01AI141003-03S1, DK063720, P30 DK063720, COVID-19, S10 RR028962, R01AI158013, 3R01AI141003
- UOUniversity of California, San Francisco
- MCMercatus Center, George Mason University
- NINational Institute of Allergy and Infectious DiseasesAwards: R01AI158013, 3R01AI141003-03S1